Indication

ET-MF

1 clinical trial

1 product

Clinical trial

A Phase 2 Study of Canakinumab in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium [MPN-RC 122]

Status: Recruiting, Estimated PCD: 2024-06-01

Product